Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Psilocybin for pain in fibromyalgia patients
2024-516890-63-00Phase 2Authorised
- Sponsor
- Maastricht University
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of psilocybin in fibromyalgia (FM) (3 arms), sponsored by Maastricht University. Planned start Jan 2025; status: authorised.
02
Drugs
psilocybin
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on 2024-516890-63-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-516890-63-00.